Literature DB >> 31259848

Prenatal Diethylstilbestrol Exposure and Risk of Depression in Women and Men.

Linda Titus1, Elizabeth E Hatch2, Julie R Palmer3, Dezheng Huo4, William C Strohsnitter5, Ervin Adam6, Winnie Ricker7, Marianne Hyer7, Robert N Hoover8, Rebecca Troisi8.   

Abstract

BACKGROUND: Prenatal exposure to diethylstilbestrol (DES), an endocrine-disrupting chemical, may be associated with depression in adulthood, but previous findings are inconsistent.
METHODS: Women (3,888 DES exposed and 1,729 unexposed) and men (1,021 DES exposed and 1,042 unexposed) participating in the National Cancer Institute (NCI) DES Combined Cohort Follow-up Study were queried in 2011 for any history of depression diagnosis or treatment. Hazard ratios (HRs; 95% confidence intervals [CIs]) estimated the associations between prenatal DES exposure and depression risk.
RESULTS: Depression was reported by 993 (26%) exposed and 405 (23%) unexposed women, and 177 (17%) exposed and 181 (17%) unexposed men. Compared with the unexposed, HRs for DES and depression were 1.1 (95% CI = 0.9, 1.2) in women and 1.0 (95% CI = 0.8, 1.2) in men. For medication-treated depression, the HRs (CIs) were 1.1 (0.9, 1.2) in women and 0.9 (0.7, 1.2) in men. In women, the HR (CI) for exposure to a low cumulative DES dose was 1.2 (1.0, 1.4), and for DES exposure before 8 weeks' gestation was 1.2 (1.0, 1.4). In men, the HR for low dose was 1.2 (95% CI = 0.9, 1.6) and there was no association with timing. In women, associations were uninfluenced by the presence of DES-related vaginal epithelial changes or a prior diagnosis of DES-related adverse outcomes.
CONCLUSIONS: Prenatal DES exposure was not associated overall with risk of depression in women or men. In women, exposure in early gestation or to a low cumulative dose may be weakly associated with an increased depression risk.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31259848      PMCID: PMC6679745          DOI: 10.1097/EDE.0000000000001048

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  22 in total

1.  Diethylstilbestrol exposure in utero and depression in women.

Authors:  Eilis J O'Reilly; Fariba Mirzaei; Michele R Forman; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2010-03-23       Impact factor: 4.897

2.  Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure.

Authors:  Frederick S vom Saal; Benson T Akingbemi; Scott M Belcher; Linda S Birnbaum; D Andrew Crain; Marcus Eriksen; Francesca Farabollini; Louis J Guillette; Russ Hauser; Jerrold J Heindel; Shuk-Mei Ho; Patricia A Hunt; Taisen Iguchi; Susan Jobling; Jun Kanno; Ruth A Keri; Karen E Knudsen; Hans Laufer; Gerald A LeBlanc; Michele Marcus; John A McLachlan; John Peterson Myers; Angel Nadal; Retha R Newbold; Nicolas Olea; Gail S Prins; Catherine A Richter; Beverly S Rubin; Carlos Sonnenschein; Ana M Soto; Chris E Talsness; John G Vandenbergh; Laura N Vandenberg; Debby R Walser-Kuntz; Cheryl S Watson; Wade V Welshons; Yelena Wetherill; R Thomas Zoeller
Journal:  Reprod Toxicol       Date:  2007-07-27       Impact factor: 3.143

3.  Prenatal diethylstilbestrol exposure and risk of breast cancer.

Authors:  Julie R Palmer; Lauren A Wise; Elizabeth E Hatch; Rebecca Troisi; Linda Titus-Ernstoff; William Strohsnitter; Raymond Kaufman; Arthur L Herbst; Kenneth L Noller; Marianne Hyer; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

4.  Serious psychiatric outcome of subjects prenatally exposed to diethylstilboestrol in the E3N cohort study.

Authors:  Helene Verdoux; Jacques Ropers; Dominique Costagliola; Françoise Clavel-Chapelon; Xavier Paoletti
Journal:  Psychol Med       Date:  2007-04-04       Impact factor: 7.723

5.  Reproductive outcomes in men with prenatal exposure to diethylstilbestrol.

Authors:  Kimberly M Perez; Linda Titus-Ernstoff; Elizabeth E Hatch; Rebecca Troisi; Jean Wactawski-Wende; Julie R Palmer; Kenneth Noller; Robert N Hoover
Journal:  Fertil Steril       Date:  2005-12       Impact factor: 7.329

6.  Psychosexual characteristics of men and women exposed prenatally to diethylstilbestrol.

Authors:  Linda Titus-Ernstoff; Kimberly Perez; Elizabeth E Hatch; Rebecca Troisi; Julie R Palmer; Patricia Hartge; Marianne Hyer; Raymond Kaufman; Ervin Adam; William Strohsnitter; Kenneth Noller; Kate E Pickett; Robert Hoover
Journal:  Epidemiology       Date:  2003-03       Impact factor: 4.822

7.  Cancer risk in men exposed in utero to diethylstilbestrol.

Authors:  W C Strohsnitter; K L Noller; R N Hoover; S J Robboy; J R Palmer; L Titus-Ernstoff; R H Kaufman; E Adam; A L Herbst; E E Hatch
Journal:  J Natl Cancer Inst       Date:  2001-04-04       Impact factor: 13.506

8.  Time to pregnancy and secondary sex ratio in men exposed prenatally to diethylstilbestrol.

Authors:  Lauren A Wise; Linda Titus-Ernstoff; Julie R Palmer; Robert N Hoover; Elizabeth E Hatch; Kimberly M Perez; William C Strohsnitter; Raymond Kaufman; Diane Anderson; Rebecca Troisi
Journal:  Am J Epidemiol       Date:  2007-06-27       Impact factor: 4.897

Review 9.  The basics of brain development.

Authors:  Joan Stiles; Terry L Jernigan
Journal:  Neuropsychol Rev       Date:  2010-11-03       Impact factor: 7.444

10.  Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study.

Authors:  Julie R Palmer; Arthur L Herbst; Kenneth L Noller; Deborah A Boggs; Rebecca Troisi; Linda Titus-Ernstoff; Elizabeth E Hatch; Lauren A Wise; William C Strohsnitter; Robert N Hoover
Journal:  Environ Health       Date:  2009-08-18       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.